Statistics
Publications
15
Citations
606
H-Index
13
Active since
2013
Xingyu Mu is an author at Shanghai First People's Hospital specializing in medicine, oncology, and molecular oncology.
Publications per year
2013–2024
15
15
FTO modifies the m6A level of MALAT and promotes bladder cancer progression
Le Tao, Xingyu Mu, Haige Chen et al. · Clinical and Translational Medicine · 2021 · 174 citations · Full text
Medicine, Bioinformatics, Oncology +13
ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation.
Jiantao Xiao, Qing Shi, Weiguo Li et al. · PubMed · 2018 · 52 citations
1–5 of 15